BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 129005)

  • 1. Hepatitis and Down's syndrome.
    Madden DL; Matthew EB; Dietzman DE; Purcell RH; Sever JL; Rostafinski M; Mata A
    Am J Ment Defic; 1976 Jan; 80(4):401-6. PubMed ID: 129005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis A and B in non-institutionalized mentally retarded patients.
    Renner F; Andrle M; Horak W; Rett A
    Hepatogastroenterology; 1985 Aug; 32(4):175-7. PubMed ID: 2932380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody to hepatitis B antigen (Australia antigen) among residents of a Finnish institution for the mentally retarded.
    Tevaluoto-Aarnio M; Werner B; London WT
    Med Biol; 1975 Feb; 53(1):51-9. PubMed ID: 124806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B infection in institutionalized Down's syndrome inmates: a longitudinal study with five hepatitis B virus markers.
    Hawkes RA; Boughton CR; Schroeter DR; Decker RH; Overby LR
    Clin Exp Immunol; 1980 Jun; 40(3):478-86. PubMed ID: 6448112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus infection among mentally retarded patients in institutions, Okinawa, Japan.
    Hayashi J; Kashiwagi S; Noguchi A; Nakashima K; Ikematsu H; Kajiyama W; Nomura H
    Fukuoka Igaku Zasshi; 1989 Sep; 80(9):436-40. PubMed ID: 2807128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis-B surface antigen and antibody: prevalence and persistence in institutionalized and noninstitutionalized persons.
    McMillan BC; Hanson RP; Golubjatnikov R; Sinha SK
    Public Health Rep; 1979 Jun; 94(3):262-7. PubMed ID: 156381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mentally deficient patients and infection caused by hepatitis B virus. Prevalence in our area].
    García Bengoechea M; Legarda JJ; Cortés A; Enríquez I; Arriola JA; Arenas JI
    Med Clin (Barc); 1989 Jun; 93(1):10-3. PubMed ID: 2528041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis-associated (Australia) antigen and Down's syndrome.
    Higgins GR; Parker CE; Faust JA; Rosenfeld M
    Am J Ment Defic; 1974 Jan; 78(4):426-8. PubMed ID: 4273154
    [No Abstract]   [Full Text] [Related]  

  • 9. Abnormal serum immunoglobulin levels in Down's syndrome patients.
    Nishida Y; Sano Y; Akaoka I; Maruki M; Suzuki T; Maruki K
    Am J Ment Defic; 1978 Jul; 83(1):16-20. PubMed ID: 150229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Response to recombinant DNA antihepatitis B vaccine in mentally retarded patients with Down's syndrome. A controlled study].
    García Bengoechea M; Cortés A; Cabriada J; Albizu I; Dorronsoro M; Arriola JA; Arenas JI
    Med Clin (Barc); 1990 Apr; 94(14):528-30. PubMed ID: 2141377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T and B lymphocytes in patients with Down's syndrome.
    Reiser K; Whitcomb C; Robinson K; MacKenzie MR
    Am J Ment Defic; 1976 May; 80(6):613-9. PubMed ID: 134638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the possible association between maternal viral hepatitis and Down's syndrome].
    Giraldo G; Ribacchi R; Bolloli D
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1966; 26(1):15-28. PubMed ID: 4223579
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiology of hepatitis B virus in an institution for mentally retarded persons.
    Madden DL; Dietzman DE; Matthew EB; Sever JL; Lander JJ; Purcell RH; Rostafinski M; Mata A
    Am J Ment Defic; 1976 Jan; 80(4):369-75. PubMed ID: 129004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infectious hepatitis and Down's syndrome: considerations on some hypothetical relationships].
    Ceccarelli G; Torbidoni L
    Pediatria (Napoli); 1967; 75(1):113-21. PubMed ID: 4234681
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatitis B markers at 3 open centers for mentally retarded].
    Devesa F; Martínez F; Moreno MJ; Sanfrancisco M; Ferrando J; Rull S
    Rev Esp Enferm Dig; 1993 Sep; 84(3):162-8. PubMed ID: 8217381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic parameters in Down's syndrome.
    Jacobs PF; Burdash NM; Manos JP; Duncan RC
    Ann Clin Lab Sci; 1978; 8(1):17-22. PubMed ID: 146453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome.
    Hann HW; Deacon JC; London WT
    Am J Ment Defic; 1979 Nov; 84(3):245-51. PubMed ID: 160754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma vitamin A levels--a diagnostic indicator of hepatitis in an institutionalized mentally retarded population.
    Curtis JL; Swicord WF
    Am J Ment Defic; 1976 Jul; 81(1):12-7. PubMed ID: 133610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down's syndrome and hepatitis: an evaluation of carrier status.
    Dicks JL; Dennis ES
    J Am Dent Assoc; 1987 May; 114(5):637-9. PubMed ID: 2955013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Occurrence of hepatitis B and C among mentally retarded].
    Lunding S; Hansen KS; Krogsgaard K; Rosdahl N; Smith E; Wantzin PS
    Ugeskr Laeger; 1999 Aug; 161(31):4393-6. PubMed ID: 10487103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.